Our study demonstrated that anti-CD47 treatment led to changes in the tumor microenvironment with increased pro-inflammatory macrophages that exhibit anti-tumor effect, while reduced anti-inflammatory macrophages that are associated with immunosuppression. This evidence concerns the gene CD47 and neoplasm.